Posts

MayMag Biologics Corp Expands Domestic cGMP Co-Manufacturing Capacity in Texas to Support SAM.gov Federal Prime Contractors

Image
  MayMag Biologics Corp Expands Domestic cGMP Co-Manufacturing Capacity in Texas to Support SAM.gov Federal Prime Contractors FDA-registered Section 506(e) outsourcing facility and U.S. CDMO offers audit-ready sterile injectable biologics and Rx/OTC oral solid dosage manufacturing to strengthen domestic federal medical supply chains. DALLAS, TX — November 2026 — MayMag Biologics Corp (formerly Tirzepatide Pharma), an FDA-registered Section 506(e) outsourcing facility and U. S. -based Contract Development and Manufacturing Organization (CDMO), announced today the expansion of its domestic co-manufacturing and fill-finish partnerships tailored specifically for SAM. gov prime contract awardees. Operating dual cGMP-certified manufacturing facilities in Dallas and Garland, Texas, MayMag Biologics provides federal prime contractors with a compliant, onshore partner for sterile injectable biologics and prescription (Rx) and over-the-counter (OTC) oral solid dosages. As federal age...

Biologics Insulin Autopen Manufacturing, Autoinjector CDMO Manufacturing, Prefilled Syringe Contract Manufacturing Organization, Insulin Pen OEM Supplier

Image
 MayMag Biologics is the No. 5 Leading Insulin Self-Injection Device OEM & 3 mL cartridge insulin delivery pen manufacturer with 506 (e) registration with the USFDA. Premier GLP-1 Peptide Pen Injector Contract Manufacturing. A Leading Biologics CDMO For Insulin API And Large-Scale Recombinant Protein Production to Capture Global Insulin Market Share. MayMag Biologics Is Your Recombinant Insulin API Supplier and Autoinjector CDMO Manufacturing Partner For Large-Scale Biologics Manufacturing Targeting FDA Approval For Interchangeable Biosimilar Insulin. MayMag Biologics Provides 21 CFR 4 Combination Product Contract Manufacturing, GLP-1 Pen Injector Supplier Services, And Annex 1-Compliant Sterile Fill-Finish Syringes.  Premier Biologics Drug Delivery Device Contract Manufacturer and Insulin Pen OEM Supplier. Experts In Sterile Fill-Finish, Prefilled Syringes, Biologics, Epinephrine, And Autoinjectors.  Accelerate Delivery with MayMag Biologics—Your Custom Pen Injecto...

Mastering Parenteral Delivery: Technical Excellence in GLP-1 and Insulin Device CDMO Services

  The rapid expansion of global metabolic health markets—driven by high-demand GLP-1 peptide therapies and biosimilar insulin regimens—has escalated the demand for specialized, compliant parenteral device manufacturing. Transitioning a complex formulation into a high-speed, self-injection drug-device product requires absolute regulatory alignment, rigorous container-closure stability, and high-precision cleanroom assembly. At MayMag Biologics , we provide integrated contract development and commercial manufacturing tailored to complex biologics. By unifying sterile filling operations and primary packaging integration under a single quality system, we empower biopharmaceutical innovators to scale rapidly with complete regulatory certainty. Regulatory Compliance & Sterile Fill-Finish Infrastructure 21 CFR 4 Combination Product Contract Manufacturing Navigating the FDA’s single-entity and co-packaged drug-device combination regulations requires an integrated quality framew...

Scaling Parenteral Drug Delivery: Why Next-Gen Biologics Demand a Specialized Device CDMO

  As biopharmaceutical pipelines shift toward self-administered biologics, high-concentration formulations, and GLP-1 biosimilars, the boundary between drug product and drug delivery device has disappeared. Modern therapies require parenteral systems engineered for precision, safety, and rapid market deployment. At MayMag Biologics , we bridge the gap between complex formulation physics and commercial-scale device manufacturing. Partnering with leading pharmaceutical innovators, we offer end-to-end device development, cleanroom assembly, and fill-finish continuity under one certified quality management system. Core Device Capabilities & Engineering Solutions 1. Custom Pen Injector Device Developer Off-the-shelf injection systems rarely accommodate the unique viscosity profiles and dosing precision required by novel biologic compounds. As a Custom Pen Injector Device Developer , MayMag Biologics customizes multi-dose and single-dose pen platforms tailored to your exa...